- Home
- PLRX vs ELTK Comparison
PLRX vs ELTK Comparison
Compare PLRX & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | ELTK |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 76.9M |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PLRX | ELTK |
|---|---|---|
| Price | $1.22 | $8.96 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $3.79 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 31.2K |
| Earning Date | 11-06-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | N/A | ★ $49,310,000.00 |
| Revenue This Year | N/A | $18.60 |
| Revenue Next Year | N/A | $9.04 |
| P/E Ratio | ★ N/A | $51.90 |
| Revenue Growth | N/A | ★ 2.54 |
| 52 Week Low | $1.10 | $7.65 |
| 52 Week High | $15.00 | $12.19 |
Technical Indicators
Market Signals| Indicator | PLRX | ELTK |
|---|---|---|
| Relative Strength Index (RSI) | 35.05 | 36.98 |
| Support Level | $1.19 | $8.55 |
| Resistance Level | $1.30 | $9.42 |
| Average True Range (ATR) | 0.12 | 0.48 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 14.42 | 22.51 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.